Table 3. Logistic analysis for factors affecting efficacy of Liuweibuqi capsules in treating patients with COPD.
| Variables | B | S.E | Wald | df | P | Exp (B) | 95% CI |
|---|---|---|---|---|---|---|---|
| INF-γ | 0.145 | 0.045 | 10.622 | 1 | 0.001 | 1.156 | 1.060–1.262 |
| IL-17 | 0.064 | 0.029 | 4.919 | 1 | 0.027 | 1.066 | 1.008–1.129 |
| IL-4 | 0.234 | 0.110 | 4.560 | 1 | 0.033 | 1.263 | 1.019–1.566 |
| Th1 | 2.193 | 1.019 | 4.630 | 1 | 0.031 | 8.961 | 1.216–66.048 |
| Th17 | 0.491 | 0.204 | 5.797 | 1 | 0.016 | 1.635 | 1.096–2.439 |
| Th2 | 1.789 | 0.888 | 4.059 | 1 | 0.044 | 5.984 | 1.050–34.111 |
| CD4+CD25+Fox3+Tregs | 0.466 | 0.162 | 8.301 | 1 | 0.004 | 1.593 | 1.161–2.187 |
| FEV1 (%) | 0.071 | 0.030 | 5.507 | 1 | 0.001 | 1.074 | 1.012–1.140 |
| FEV1/FVC (%) | 9.368 | 2.606 | 12.918 | 1 | 0.019 | 11,708.259 | 70.769–11,708.259 |
| Smoking | 2.435 | 0.859 | 8.046 | 1 | <0.001 | 11.421 | 2.123–61.458 |
| Liuweibuqi capsules | 0.145 | 0.045 | 10.622 | 1 | 0.005 | 1.156 | 1.060–1.262 |
COPD, chronic obstructive pulmonary disease; Tregs, regulatory T cells; Th, helper T cells; FEV1, forced expiratory volume in one second; FVC, forced vital capacity.